Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Evol Biol ; 31(4): 530-542, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29446196

RESUMEN

Large comparative studies in animal ecology, physiology and evolution often use animals reared in the laboratory for many generations; however, the relevance of these studies hinges on the assumption that laboratory populations are still representative for their wild living conspecifics. In this study, we investigate whether laboratory-maintained and freshly collected animal populations are fundamentally different and whether data from laboratory-maintained animals are valid to use in large comparative investigations of ecological and physiological patterns. Here, we obtained nine species of Drosophila with paired populations of laboratory-maintained and freshly collected flies. These species, representing a range of ecotypes, were assayed for four stress-tolerance, two body-size traits and six life-history traits. For all of these traits, we observed small differences in species-specific comparisons between field and laboratory populations; however, these differences were unsystematic and laboratory maintenance did not eclipse fundamental species characteristics. To investigate whether laboratory maintenance influence the general patterns in comparative studies, we correlated stress tolerance and life-history traits with environmental traits for the laboratory-maintained and freshly collected populations. Based on this analysis, we found that the comparative physiological and ecological trait correlations are similar irrespective of provenience. This finding is important for comparative biology in general because it validates comparative meta-analyses based on laboratory-maintained populations.


Asunto(s)
Técnicas de Cultivo , Drosophila/fisiología , Animales , Composición Corporal , Femenino , Rasgos de la Historia de Vida , Estrés Fisiológico
2.
Heredity (Edinb) ; 115(4): 293-301, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25690179

RESUMEN

Phenotypic plasticity is ubiquitous and generally regarded as a key mechanism for enabling organisms to survive in the face of environmental change. Because no organism is infinitely or ideally plastic, theory suggests that there must be limits (for example, the lack of ability to produce an optimal trait) to the evolution of phenotypic plasticity, or that plasticity may have inherent significant costs. Yet numerous experimental studies have not detected widespread costs. Explicitly differentiating plasticity costs from phenotype costs, we re-evaluate fundamental questions of the limits to the evolution of plasticity and of generalists vs specialists. We advocate for the view that relaxed selection and variable selection intensities are likely more important constraints to the evolution of plasticity than the costs of plasticity. Some forms of plasticity, such as learning, may be inherently costly. In addition, we examine opportunities to offset costs of phenotypes through ontogeny, amelioration of phenotypic costs across environments, and the condition-dependent hypothesis. We propose avenues of further inquiry in the limits of plasticity using new and classic methods of ecological parameterization, phylogenetics and omics in the context of answering questions on the constraints of plasticity. Given plasticity's key role in coping with environmental change, approaches spanning the spectrum from applied to basic will greatly enrich our understanding of the evolution of plasticity and resolve our understanding of limits.


Asunto(s)
Evolución Biológica , Ambiente , Aptitud Genética , Fenotipo , Adaptación Biológica/genética , Variación Genética , Selección Genética
3.
Curr Neurol Neurosci Rep ; 1(3): 277-85, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11898530

RESUMEN

The treatment of relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis, has been revolutionized in recent years. In addition to effective treatment of acute relapses, therapies are now available to prevent relapses, reduce the burden of disease as seen on magnetic resonance imaging, and possibly even slow the course of disease. There are now several agents either approved, awaiting approval, or in various stages of development in many countries. Evidence suggests that early intervention with these agents will yield the best results in the long run. The current approach to treatment of RRMS is the focus of this discussion.


Asunto(s)
Enfermedades Autoinmunes/terapia , Inmunoterapia , Esclerosis Múltiple/terapia , Adyuvantes Inmunológicos/uso terapéutico , Corticoesteroides/uso terapéutico , Antiinflamatorios/uso terapéutico , Enfermedades Autoinmunes/tratamiento farmacológico , Enfermedades Autoinmunes/epidemiología , Enfermedades Autoinmunes/inmunología , Azatioprina/uso terapéutico , Ensayos Clínicos como Asunto , Ciclofosfamida/uso terapéutico , Progresión de la Enfermedad , Esquema de Medicación , Predicción , Acetato de Glatiramer , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Inmunosupresores/uso terapéutico , Interferón beta-1a , Interferon beta-1b , Interferón beta/uso terapéutico , Estudios Longitudinales , Metotrexato/uso terapéutico , Mitoxantrona/uso terapéutico , Esclerosis Múltiple/tratamiento farmacológico , Esclerosis Múltiple/epidemiología , Esclerosis Múltiple/inmunología , Péptidos/uso terapéutico , Intercambio Plasmático , Plasmaféresis , Esteroides , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...